The GAIN Study: Understanding What Helps Children Learn to Like and Eat New Foods

September 8, 2020 updated by: University of Colorado, Denver

Nutrition supplements have tremendous impact upon the nutritional and developmental status of malnourished children. These products have been designed to be acceptable to children (often by adding nutritive sweeteners to make them more palatable), but to date there has been little rigorous testing of their palatability for infants, toddlers and young children. The overall goal of this project is to investigate whether:

  1. children's acceptance of a nutrition supplement is associated with maternal persistence in offering the food to her child over a 2-week period;
  2. an unsweetened version of the nutrition supplement differs in short- and long-term acceptance; and
  3. maternal liking of the supplement is associated with her persistence in offering the food to her child.

Study Overview

Status

Completed

Detailed Description

More rigorous pre-testing of nutrition supplements, with a focus on palatability (i.e., observations of behavioral and facial responses to its taste) and its relation to children's acceptance (defined here as consumption), could provide important insights into the capacity for these products to transition from being perceived as "medicine" to being accepted as "food," or part of the usual child diet. A clearer understanding of the relation between observed child indicators of palatability and acceptance, both initially and over time (i.e., repeated exposure effects), is important for predicting the longer-term impacts on children's dietary intake, growth and health. Further, a better grasp of caregiver perceptions of the acceptability of these products, both their child's and their own, is critical in paving the way for overcoming barriers and identifying facilitators associated with longer-term acceptance of these nutritional supplements.

We secondarily will also explore the effects of potential mediators on caregiver persistence and infant acceptance of a sweetened and an unsweetened small-quantity lipid nutrition supplement (SQ-LNS) such as:

  • Maternal feeding self-efficacy
  • Caregiver food neophobia
  • Caregiver feeding styles using the Infant Feeding Style Questionnaire
  • Infant feeding history and food experience
  • Toddler eating behaviors using the Child Eating Behavior Questionnaire for Toddlers
  • Infant behaviors using the Infant Behavior Questionnaire-Revised (Garstein & Rothbart 2003 Inf Behav Dev)

Study Type

Observational

Enrollment (Actual)

58

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Colorado
      • Aurora, Colorado, United States, 80045
        • University of Colorado Denver

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

7 months to 2 years (CHILD)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Infants and toddlers and their caregivers will be recruited for this study via:

  • printed advertisements placed in a number of community and healthcare venues and posted on online websites.
  • emails sent through the university
  • referrals from other participating caregivers

Description

Inclusion Criteria:

  • Term birth (at least 37 weeks gestation)
  • Experience with complementary foods
  • Previous exposure to nuts (butters, powders, or other nut ingredients)
  • Caregiver at least 18 years of age and < 51 years of age
  • Caregiver lives within 75 miles of the University of Colorado Anschutz Medical Campus
  • Caregiver must feed the infant or toddler at least 50% of the time

Exclusion Criteria:

  • Has a genetic disorder or developmental disability, as these conditions often result in feeding difficulties
  • Has a reported illness or metabolic disorder (e.g., food allergy) that could affect food intake
  • Was born prematurely (< 37 weeks gestation)
  • Caregiver is less than 18 years of age
  • Caregiver lives more than 75 miles from the University of Colorado Anschutz Medical Campus
  • Caregiver does not read and speak English
  • Caregiver has a food allergy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Unsweetened Supplement
Infants will receive 10 exposures to the unsweetened small quantity lipid nutritional supplement (SQ-LNS) at home
Sweetened Supplement
Infants will receive 10 exposures to the sweetened small quantity lipid nutritional supplement (SQ-LNS) at home

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in rate of infant acceptance of sweetened and unsweetened nutritional supplement
Time Frame: Baseline, Week 2
Acceptance is measured at the conclusion of each offered bite using an adaptation of the Feeding Infants: Behavior and Facial Expression Coding System (FIBFECS) on a 4-point scale from 0-3 where 0 = refusal and 3 = early acceptance of food
Baseline, Week 2
Change in infant consumption of sweetened and unsweetened nutritional supplement
Time Frame: Baseline up to Week 2
Consumption of each type of supplement will be measured in grams. The weight of the remainder of each supplement will be subtracted from the initial weight of the supplement prior to offering. The remainder of the supplements offered at home will be frozen and returned to the lab to be weighed.
Baseline up to Week 2

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Baseline caregivers' perceived ratings of infant liking of sweetened and unsweetened supplements
Time Frame: Baseline
After feeding each version of the supplement, the caregiver will be instructed to rate how much he/she thought his/her infant liked the supplement by placing a mark on a 100 mm visual analog scale (VAS) ranging from "dislikes extremely" to "likes extremely". The distance of the caregivers' marking on the 100mm line is measured from "dislikes extremely" in mm, with higher measurement values meaning caregivers perceive the infants like the supplement more.
Baseline
Follow up caregivers' perceived ratings of infant liking of sweetened and unsweetened supplements
Time Frame: Visit two: change from baseline caregivers' perceived ratings at two weeks
After feeding each version of the supplement, the caregiver will be instructed to rate how much he/she thought his/her infant liked the supplement by placing a mark on a 100 mm visual analog scale (VAS) ranging from "dislikes extremely" to "likes extremely". The distance of the caregivers' marking on the 100mm line is measured from "dislikes extremely" in mm, with higher measurement values meaning caregivers perceive the infants like the supplement more.
Visit two: change from baseline caregivers' perceived ratings at two weeks
Baseline caregivers' perceived acceptability of the sweetened and unsweetened supplements
Time Frame: Baseline
After feeding each version of the supplement, the caregiver will be instructed to rate how likely they would be to serve each supplement again by placing a mark on a 100 mm visual analog scale (VAS) ranging from "not at all likely" to "extremely likely". The distance of the caregivers' marking on the 100mm line is measured from "not at all likely" in mm, with higher measurement values meaning caregivers are more likely to serve the supplement again.
Baseline
Follow up caregivers' perceived acceptability of the sweetened and unsweetened supplements
Time Frame: Visit two: change from baseline caregivers' acceptability ratings at two weeks
After feeding each version of the supplement, the caregiver will be instructed to rate how likely they would be to serve each supplement again by placing a mark on a 100 mm visual analog scale (VAS) ranging from "not at all likely" to "extremely likely". The distance of the caregivers' marking on the 100mm line is measured from "not at all likely" in mm, with higher measurement values meaning caregivers are more likely to serve the supplement again.
Visit two: change from baseline caregivers' acceptability ratings at two weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Matthew Greenhawt, MD, University of Colorado, Denver

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

October 25, 2018

Primary Completion (ACTUAL)

April 1, 2019

Study Completion (ACTUAL)

April 1, 2019

Study Registration Dates

First Submitted

August 28, 2020

First Submitted That Met QC Criteria

September 8, 2020

First Posted (ACTUAL)

September 10, 2020

Study Record Updates

Last Update Posted (ACTUAL)

September 10, 2020

Last Update Submitted That Met QC Criteria

September 8, 2020

Last Verified

September 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • 17-2308

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

Data may be available upon request to the Principal Investigator (SL Johnson)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Parenting

3
Subscribe